Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Genes and microbes converge in colitis: Both host genetics and intestinal microbes probably contribute to a person's overall susceptibility to inflammatory bowel disease (IBD). The human gut microbe Bacteroides fragilis produces immunomodulatory molecules that it releases via outer membrane vesicles (OMVs). These molecules can protect mice from experimentally induced colitis. Chu et al. now find that OMV-mediated protection from colitis requires Atg16l1 and Nod2 genes whose human orthologs are associated with an increased risk for developing IBD. OMVs trigger an ATG16L1 and NOD2–dependent noncanonical autophagy pathway in dendritic cells (DCs). OMV-primed DCs, in turn, induce regulatory T cells in the intestine that protect against colitis. Science , this issue p. 1116
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“commensal Bacteroides fragilis‐induced activation of LAP drives a transcriptionally tolerogenic program of differentiation in antigen‐presenting cells, which is required to generate immunosuppressive TREG cells in the context of colitis (Chu et al, 2016).”
From Autophagy in major human diseases (2021) · cites this paper as Chu et al, 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Martinez, J., Malireddi, R. K. S., Lu, Q., Cunha, L. D., Pelletier, S., Gingras, S., Orchard, R., Guan, J.-L., Tan, H., Peng, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3192 · Cited by 758 · cited 12×
“Data are representative of at least three independent experiments, with three to nine mice per group. a known product of LAP activation (36), but at significantly reduced levels in Nod2−/− or Tlr2−/− DCs (fig.”
BackgroundInfluentialSelf-citationRetractedGenome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385 · cited 2×
“Intestinal microbiota modulate development and function of the immune system, and play a critical role in inflammatory bowel disease (IBD), a family of idiopathic intestinal disorders including Crohn’s disease (CD) and ulcerative colitis (UC) (1-6).”
BackgroundA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722 · cited 2×
“published online EpubJan (S0016-5085(11)01378-3 [pii]10.”
Self-citationInteractions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“Intestinal microbiota modulate development and function of the immune system, and play a critical role in inflammatory bowel disease (IBD), a family of idiopathic intestinal disorders including Crohn’s disease (CD) and ulcerative colitis (UC) (1-6).”
BackgroundAntimicrobial Autophagy: A Conserved Innate Immune Response in Drosophila
Moy, R. H., & Cherry, S. (2013) · Journal of Innate Immunity · doi:10.1159/000350326 · Cited by 3,539
A microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340 · cited 1×
“fragilis capsular Polysaccharide A (PSA) is packaged in outer membrane vesicles (OMVs) and delivered to intestinal dendritic cells to induce interleukin-10 (IL-10) production from CD4+Foxp3+ regulatory T cells (Tregs), which protect from experimental colitis (30-32).”
BackgroundSelf-citation
Cited by
Items 601–645 of 645
Bone, B., Griffith, L., Jefferson, M. A., Yamauchi, Y., Wileman, T. E., & Powell, P. P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.09.627529
Research Progress on the Pathogenesis of Crohn’s Disease: Genetic, Environmental, and Immune Factors
陈, 昌. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153690
Li, Y., Chen, Y., Shen, K., Feng, Y. X., Xie, Z., Wang, H., & Lu, C. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5356128
Ren, S., Wei, W., Liu, X., Kang, X., Liu, J., Zhai, W., Zhang, Y., Chuai, Q., Hu, B., Liu, J., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1656575 · Cited by 1
Plasma protein increase as a chronological aging factor in healthy toy poodles
Ozaki, S., Honme, Y., Higashi, S., Hattori, K., Morifuji, M., Mizuno, E., Yoshida, M., & Ito, T. K. (2025) · Scientific Reports · doi:10.1038/s41598-025-26154-2
Xiang, P., Ge, T., Zhou, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26562694
Gong, Y., Shen, S., Cao, Z., Zou, X., Zhou, S., Jiang, R., Kang, X., Liu, S., & Tian, Y. (2026) · Animal Microbiome · doi:10.1186/s42523-025-00514-9
“Essentially, many chronic and degenerative diseases in broilers and humans, such as necrotic enteritis and inflammatory bowel disease, are caused by dysbiosis of the gut microbiome and excessive proliferation of pathogenic bacteria [13, 14].”
Marseglia, A., Nieto‐Fabregat, F., Carluccio, C. D., Molinaro, A., Silipo, A., & Marchetti, R. (2026) · RENDICONTI LINCEI · doi:10.1007/s12210-026-01405-0
Die Rolle des Mikrobioms bei chronisch-entzündlichen Darmerkrankungen
Cira, K., & Neumann, P. (2026) · coloproctology · doi:10.1007/s00053-026-00946-0
Role of the gut microbiome in the pathogenesis of inflammatory bowel disease
Banerjee, S., Adhikary, P., De, D., Kalam, A., Chowdhury, S., & Mal, C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40483-2.00021-2
Tanoorjeh, M. S., Sardou, H. S., Feizollahi, S., Kesharwani, P., Abbaspour, M., & Sahebkar, A. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.117838
Drajac, C. (2018) · theses.fr (ABES) · doi:10.70675/d60e1c2bz42b4z4ea3z8b51z6099a730ffad · Cited by 2
Cornuault, J. K. (2018) · theses.fr (ABES) · doi:10.70675/55d00c01zb915z43d1z8f0bzeead74fa3383 · Cited by 2
Impact of microbiota on intestinal stem cells survival after irradiation
Lévy, A. (2018) · theses.fr (ABES) · doi:10.70675/b6ab24a4zf5fdz489ezb1b1za2f33c2c0847
Réplication et séquestration du VIH-1 dans les macrophages
Lepont, L. (2020) · theses.fr (ABES) · doi:10.70675/40f6be5ez97e5z4043za0cdz0099a87dd935
Impact du microbiote intestinal sur les surinfections bactériennes post-grippales
Sencio, V. (2020) · theses.fr (ABES) · doi:10.70675/15f9ad6cz34d4z4d8azac75zece70c0fd094
He, Z., Chi, X., Ruan, S., Lin, R., Chen, H., Cai, K., Ye, X., Hu, J., He, H., Li, L., et al. (2026) · BMC Genomics · doi:10.1186/s12864-026-12865-x
“Previous studies showed that microbiota could affect host gene expression, thereby influencing intestinal function [54, 55].”
Dong, J., Dou, J., Zhu, L., Zhang, L. H., Bo, Y., Liang, Z., Meng, X., Wang, X. L., Wang, T., Sun, M., et al. (2026) · Medicine · doi:10.1097/md.0000000000044003
Wang, Z., Zhu, F., Zhang, J., Feng, K., Abudourexiti, W., Li, S., Guo, Y., Chen, M., Yu, Z., Zhao, L., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103211 · Cited by 2
“Gut microbiota dysbiosis has been strongly implicated in UC development [4].”
Khan, M. Z., Ullah, A., Qadeer, A., Li, Y., Alsharif, K. F., Alzahrani, F. M., Alzahrani, K. J., Abuderman, A., Ma, Q., & Wang, C. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108466
The endogenous peptide GPR15L shapes the intestinal microbiota to counteract colitis
Leggio, M., Schramm, S., Dietz, L., Ocón, B., Wirtz, S. J., Balint, F. P., Yılmaz, B., Petzold, J., Liu, L., Dedden, M., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-337619 · Cited by 2
“On the other hand, in the absence of GPR15L, Bacteroides and taxa such as Lachnoclostridium that have been associated with IBD 30 37 39 were enriched and key commensals such as Roseburia or Rikenella 34–36 decreased in their abundance.”
Pi, Z., Shi, J., Tang, Z., Yang, F., Li, H., & Cheng, S. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6883861
Hasanian-Langroudi, F., Yaghmaei, H., Soroush, E., Talifar, H., Meskini, M., & Siadat, S. D. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11083-x · Cited by 2
Bacterial extracellular vesicles in inflammatory diseases: emerging roles and mechanisms
Yang, C., Bai, M., Wan, Y., Qian, Y., Li, Z., Zheng, Q., Lv, L., Zhang, Y., Fan, Z., Yang, H., et al. (2026) · Regenerative Biomaterials · doi:10.1093/rb/rbag129 · Cited by 2
Surface-coated probiotics: engineered living platforms for targeted IBD therapy
Li, H., Cong, J., Wang, K., Wen, C., Xu, L., Xu, X., Zhang, Y., & Liang, Y. (2026) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-026-01920-6
Dutta, A. K., Abraham, D., Benny, B., Govindan, K., & Joseph, A. J. (2026) · Indian Journal of Gastroenterology · doi:10.1007/s12664-026-02031-2
Shi, W., Liu, Y., Liu, Y., Liu, S., Shi, M., Du, J., Liu, X., & Xu, N. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154296
Xu, H., Xu, J. Q., Zhang, Y., Tan, Y., Zhu, S., Han, N., Lv, Y., Wang, M., Liu, Y., Ren, J., et al. (2026) · MedComm – Future Medicine · doi:10.1002/mef2.70063
Singh, A., Zhang, Y., Ding, J., Shi, Q., Saleh, A. M., Jones, J., Xiao, X., Lee, Y.-Y., Weyant, K. B., DeLisa, M. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.01.732738
Zhang, Q., Zhang, B., Aazmi, M. S., Chen, L., & Yahya, M. F. Z. R. (2026) · Biomolecules · doi:10.3390/biom16081132 · Cited by 1
“Further studies found that B. fragilis BEVs-mediated immune regulation was related to autophagy genes in the non-standard autophagy pathway [81].”
Li, W., Yuan, Y., Li, X., & Zhou, J. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1851847
“Polymorphisms in genes like CARD9 and ATG16L1 disrupt beneficial host–microbe dialogues, impairing the production of protective metabolites (Lamas et al., 2016; Chu et al., 2016).”
Multidimensional interactions of living materials with biological entities
Shuqing, D., Liu, Y., Liu, Y., Tan, Y., Man, Y., Zhang, Z., Lv, Z., Lee, L. P., Chen, Q., & Liu, Z. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124565
The microbiota-NK cell axis in colorectal cancer: a spatial and subset-centric framework
Wen, J., Gao, Y., Xu, M., Li, M., Dong, X., Zhao, M., Xuan, B., Meng, X., He, L., Zhang, W., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1934819
Oka, A., Bongers, G., Mishima, Y., Baltus, A. E., Gray, S. M., Liu, B., Herzog, J., Benedetto, J. R., Fan, T.-J., Jang, J., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.08.003 · Cited by 2
Paudel, M. S., Sharma, V., Bhattarai, K., Birda, C. L., Goel, K., Yadav, A., Chaurasia, S., Shrestha, M., & Ranjan, M. K. (2026) · Indian Journal of Gastroenterology · doi:10.1007/s12664-026-02078-1
Talekar, S., Lade, V., & Ghosh, S. (2026) · International Reviews of Immunology · doi:10.1080/08830185.2026.2736246
Cheng, X., Yang, Y., Ding, H., Huang, R., 曹双双, 史润选, Qi, G., Wang, S., Ma, G., Wei, W., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124675
Onohuean, H., Igere, B. E., Thalluri, C., Bukke, S. P. N., Nnolum-Orji, N. F., Onyemarim, H., Onyemarin-Henry, P. A., & Choonara, Y. E. (2026) · Extracellular Vesicle · doi:10.1016/j.vesic.2026.100111
Hou, X., Guo, P., Wang, S., Yuan, Y., Wei, W., & Zheng, D. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100599
Gut Microbiota-Derived Extracellular Vesicles in Cancer: Friends or Foes?
Selim, H. M. R. M., Abdallah, D. M., El-Gazar, A. A., Abo-Zalam, H. B., Ragab, G. M., El-Gazar, R. A., Ali‐Tammam, M., & El-Abhar, H. S. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11227-z
Liu, C., Chen, H., Chen, F., Lu, Z., Chen, Y., Huang, X., Guo, M., Li, C., Wang, L., & Wang, Y. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.10.016
郭亚南, Nurxat, N., Wang, Q., Shen, Z., Zhao, N., Liu, Y., Jian, Y., Ye, B., Li, M., & Liu, Q. (2026) · iScience · doi:10.1016/j.isci.2026.117969
“38 Our animal model suggested that B . fragilis and its intact OMVs are capable of inducing functional autophagy in macrophages, thereby facilitating the clearance of pathogenic bacteria (Figure 6).”
Metadata
- Authors
- Chu, H., Khosravi, A., Kusumawardhani, I. P., Kwon, A. H. K., Vasconcelos, A. C., Cunha, L. D., Mayer, A. E., Shen, Y., Wu, W.-L., Kambal, A., Targan, S. R., Xavier, R. J., Ernst, P. B., Green, D. R., McGovern, D. P. B., Virgin, H. W., & Mazmanian, S. K.
- Affiliations
- California Institute of Technology (US)
- University of California San Diego (US)
- St. Jude Children's Research Hospital (US)
- Washington University in St. Louis (US)
- Cedars-Sinai Medical Center (US)
- Harvard University (US)
- Corresponding author
- Chu, Hiutung
- Mazmanian, Sarkis K.
- ORCID
- Venue
- Science
- Published
- 2016-05-27
- Volume
- 352
- Issue
- 6289
- Pages
- 1116-1120
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4996125
- OpenAlex
- W2346233234
- Cited by
- 647
- References
- 48
- Citations by year
- 2026: 50 · 2025: 55 · 2024: 60 · 2023: 64 · 2022: 57 · 2021: 69 · 2020: 68 · 2019: 77 · 2018: 56 · 2017: 65 · 2016: 24
- FWCI
- 59.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Institutes of Health (NIH)
- Ruth L. Kirschtein National Research Service Award (DK100109)
- Cedars-Sinai F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute Research Funds
- Feintech Family Chair
- Wayne and Gladys Valley Foundation
- Lupus Research Institute
- Lisa Z. Greer Endowed Chair
- European Union (305479)
- Leona M. and Harry B. Helmsley Charitable Trust
- NIH (DK097485, PO1DK046763, AI079145, AI40646, U19 AI109725, DK062413, DE023789-01, AI109725, DK078938, GM099535)
- Crohn's and Colitis Foundation of America
- Heritage Medical Research Institute
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- inflammatory bowel disease, Bacteroides fragilis, outer membrane vesicles, ATG16L1, NOD2, non-canonical autophagy, dendritic cells, regulatory T cells, colitis, gut dysbiosis, susceptibility genes, mucosal inflammation
- MeSH terms
- Extracellular Vesicles, Gastrointestinal Microbiome, Autophagy-Related Proteins, Adult, Aged, Animals, Autophagy, Bacteroides fragilis, Carrier Proteins, Dendritic Cells, Female, Humans, Intestinal Mucosa, Male, Mice, Inbred C57BL, Middle Aged, Polymorphism, Genetic, Inflammatory Bowel Diseases, Genome, Human, Genetic Predisposition to Disease, T-Lymphocytes, Regulatory, Mice, Nod2 Signaling Adaptor Protein, Gene-Environment Interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.